- Coordinates
 - PDB Format
 - Method
 - ELECTRON MICROSCOPY
 - Oligo State
 - homo-trimer
 - Ligands
 - 1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - 13 x NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - 34 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 NAG.15: 3 residues within 4Å:- Chain A: F.341, N.342, F.370
 
Ligand excluded by PLIPNAG.16: 3 residues within 4Å:- Chain A: N.330, P.577, Q.578
 
Ligand excluded by PLIPNAG.17: 3 residues within 4Å:- Chain A: N.614, T.616, E.617
 
Ligand excluded by PLIPNAG.18: 1 residues within 4Å:- Chain A: N.655
 
Ligand excluded by PLIPNAG.19: 3 residues within 4Å:- Chain A: S.706, N.707
 - Chain C: Y.794
 
Ligand excluded by PLIPNAG.20: 5 residues within 4Å:- Chain A: A.704, E.1070, K.1071, N.1072
 - Chain C: Q.893
 
Ligand excluded by PLIPNAG.21: 4 residues within 4Å:- Chain A: Y.31, T.32, N.33, N.64
 
Ligand excluded by PLIPNAG.22: 5 residues within 4Å:- Chain A: N.123, T.125, N.126, F.128, V.171
 
Ligand excluded by PLIPNAG.23: 3 residues within 4Å:- Chain A: E.133, N.165
 - Chain B: R.356
 
Ligand excluded by PLIPNAG.24: 2 residues within 4Å:- Chain A: N.233, T.235
 
Ligand excluded by PLIPNAG.25: 2 residues within 4Å:- Chain A: N.281
 - Chain B: K.556
 
Ligand excluded by PLIPNAG.26: 6 residues within 4Å:- Chain B: N.123, A.124, T.125, N.126, F.128, V.171
 
Ligand excluded by PLIPNAG.27: 3 residues within 4Å:- Chain B: Y.31, F.62, N.64
 
Ligand excluded by PLIPNAG.28: 5 residues within 4Å:- Chain B: S.113, K.114, E.133, N.164, N.165
 
Ligand excluded by PLIPNAG.29: 6 residues within 4Å:- Chain B: T.109, N.233
 - Chain C: K.461, E.464, R.465, D.466
 
Ligand excluded by PLIPNAG.30: 2 residues within 4Å:- Chain B: N.330, Q.578
 
Ligand excluded by PLIPNAG.31: 2 residues within 4Å:- Chain B: N.614, T.616
 
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain B: Y.653, N.655
 
Ligand excluded by PLIPNAG.33: 3 residues within 4Å:- Chain A: Y.794
 - Chain B: S.706, N.707
 
Ligand excluded by PLIPNAG.34: 4 residues within 4Å:- Chain A: Q.893
 - Chain B: A.704, E.1070, N.1072
 
Ligand excluded by PLIPNAG.35: 4 residues within 4Å:- Chain B: H.338, F.341, N.342, F.370
 
Ligand excluded by PLIPNAG.36: 3 residues within 4Å:- Chain B: A.347, N.353, R.465
 
Ligand excluded by PLIPNAG.37: 2 residues within 4Å:- Chain C: N.614, T.616
 
Ligand excluded by PLIPNAG.38: 2 residues within 4Å:- Chain C: Y.653, N.655
 
Ligand excluded by PLIPNAG.39: 4 residues within 4Å:- Chain B: I.792, Y.794
 - Chain C: S.706, N.707
 
Ligand excluded by PLIPNAG.40: 5 residues within 4Å:- Chain B: Q.893
 - Chain C: A.704, E.1070, K.1071, N.1072
 
Ligand excluded by PLIPNAG.41: 3 residues within 4Å:- Chain C: Y.31, T.32, N.64
 
Ligand excluded by PLIPNAG.42: 4 residues within 4Å:- Chain C: N.123, A.124, T.125, F.128
 
Ligand excluded by PLIPNAG.43: 3 residues within 4Å:- Chain C: A.163, N.164, N.165
 
Ligand excluded by PLIPNAG.44: 3 residues within 4Å:- Chain C: T.109, N.233, T.235
 
Ligand excluded by PLIPNAG.45: 3 residues within 4Å:- Chain C: N.279, E.280, N.281
 
Ligand excluded by PLIPNAG.46: 2 residues within 4Å:- Chain C: N.330, V.331
 
Ligand excluded by PLIPNAG.47: 5 residues within 4Å:- Chain C: H.338, E.339, N.342, A.343, F.370
 
Ligand excluded by PLIPNAG.48: 3 residues within 4Å:- Chain C: A.347, N.353, T.355
 
Ligand excluded by PLIP- 1 x IDU: 2-O-sulfo-beta-L-altropyranuronic acid(Non-functional Binders)
 - Links
 - RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
 - Citation
 - Liu, P. et al., Spike N354 glycosylation augments SARS-CoV-2 fitness for human adaptation through structural plasticity. Natl Sci Rev (2024)
          


 - Release Date
 - 2024-07-03
 - Peptides
 - Spike glycoprotein: ABC
 - SMTL:PDB
 - SMTL Chain Id:
PDB Chain Id:A
AB
BC
C 
- Coordinates
 - PDB Format
 - Method
 - ELECTRON MICROSCOPY
 - Oligo State
 - homo-trimer
 - Ligands
 - 1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - 13 x NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - 34 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - 1 x IDU: 2-O-sulfo-beta-L-altropyranuronic acid(Non-functional Binders)
 - Links
 - RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
 - Citation
 - Liu, P. et al., Spike N354 glycosylation augments SARS-CoV-2 fitness for human adaptation through structural plasticity. Natl Sci Rev (2024)
          


 - Release Date
 - 2024-07-03
 - Peptides
 - Spike glycoprotein: ABC
 - SMTL:PDB
 - SMTL Chain Id:
PDB Chain Id:A
AB
BC
C